Literature DB >> 31023208

Treatment of posterolateral tibial plateau fractures through fibular osteotomy approach.

Guanghui Zhao, Qiang He, Honghao Duan, Jianbing Ma.   

Abstract

The best approach for treating posterolateral tibial plateau fractures remains controversial. The aim of the present study was to evaluate the outcomes of patients with posterolateral tibial plateau fractures after open reduction and internal fixation with the fibular osteotomy approach. Between January 2009 and July 2012, twelve patients with posterolateral tibial plateau fracture were treated using the fibular osteotomy approach with a proximal tibia locking compression plate. The epidemiological data, operation details, and clinical outcomes over 25.6 ± 2.1 months (range, 22-38 months) of follow-up were prospectively collected and analyzed. The average surgical duration was 92.5 ± 14.5 min (range, 83-107 min). An anatomical reduction rate of 91.7% (11/12) was observed, although one patient with a lateral comminuted fracture and dislocation had a 2-mm joint surface depression postoperatively. The average fracture healing time was 11.6 ± 3.1 weeks (range, 8-15 weeks), with an average hospital for special surgery knee score of 94.1 ± 3.2 points (range, 80-100 points), an average knee flexion of 118.6° ± 18.1° (range, 96°-138°) and an average knee extension of 1.9° ± 2.2° (range, 0°-6.3°). No complications were found. The fibular osteotomy approach with a proximal tibial compression plate can produce a satisfactory clinical outcome for patients with posterolateral tibial plateau fractures.

Entities:  

Mesh:

Year:  2019        PMID: 31023208

Source DB:  PubMed          Journal:  Acta Orthop Belg        ISSN: 0001-6462            Impact factor:   0.500


  1 in total

1.  [Application of modified anterolateral supra-fibular-head approach in treatment of tibial plateau fractures involving posterolateral column].

Authors:  Bo Zu; Jianjun Wang; Jinrui Liu; Zhi Chen
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-06-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.